Earnings Call · Q4 FY2021·2022-02-17

Q4 21EPS +4.26%·Rev n/aQ3 21EPS +11.11%·Rev n/aQ2 21EPS +27.27%·Rev n/aQ1 21EPS +32.43%·Rev n/a⚠ consensus missing

GLOBUS MEDICAL INC GMED

Brian Kearns — Senior Vice President of Business Development and Investor Relations

David Demski — President and CEO

Keith Pfeil — Senior Vice President and Chief Financial Officer

−0.1%1d on move date+0.5% vs SPY3d−0.1%5d+5.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more GMED calls or request research access.

More GMED calls Browse calls Request research access